| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |